Adipokines: Unveiling the Intricate Communication Network of Adipose Tissue

Andrew Marcin^*
*Correspondence: Andrew Marcin, Department of Health Human Performance and Recreation, Baylor University, TX, USA, Email:

Keywords

Adipose tissue • Inflammation • Insulin resistance

Introduction

Adipose tissue, once regarded as a simple energy storage depot, is now recognized as a highly active and dynamic endocrine organ. It secretes numerous bioactive molecules known as adipokines, which play pivotal roles in regulating metabolic homeostasis, inflammation, and overall health. Over the past few decades, extensive research has shed light on the intricate communication network mediated by adipokines, unraveling their diverse functions and potential implications in various physiological and pathological processes. This article aims to provide an in-depth understanding of adipokines, their classification, physiological roles, and their association with metabolic disorders and chronic diseases. Adipokines encompass a broad array of molecules that are predominantly secreted by adipocytes, the primary cell type within adipose tissue. They can be classified into several categories based on their functions and origins. The major groups of adipokines include adiponectins, leptin, pro-inflammatory cytokines, anti-inflammatory cytokines, chemokines, and growth factors. Adiponectins, notably adiponectin-1 and adiponectin-2, are among the most extensively studied adipokines. They exhibit insulin-sensitizing, anti-inflammatory, and anti-atherogenic properties [1].

Adiponectins play a critical role in modulating glucose and lipid metabolism, promoting insulin sensitivity, and reducing systemic inflammation. Low levels of adiponectin are often associated with obesity, insulin resistance, and cardiovascular diseases. Leptin, known as the "satiety hormone," is primarily produced by adipocytes and regulates energy balance by signaling the brain about the body's energy stores. Leptin acts on the hypothalamus to suppress appetite and increase energy expenditure. In conditions of leptin deficiency or resistance, such as in obesity, leptin signaling becomes impaired, leading to dysregulation of energy balance and increased appetite. Several pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β), are secreted by adipose tissue. These cytokines contribute to chronic low-grade inflammation observed in obesity and insulin resistance. They promote the recruitment of immune cells, induce insulin resistance, and impair glucose metabolism, thereby linking obesity to the development of metabolic disorders. Adipose tissue also produces anti-inflammatory cytokines, such as interleukin-10 (IL-10) and interleukin-1 receptor antagonist (IL-1Ra).

The cytokines counteract the pro-inflammatory effects of adipokines and help maintain immune homeostasis. However, their exact roles in metabolic regulation and inflammation require further exploration. Chemokines are small signaling proteins that play crucial roles in immune cell recruitment and activation. Adipose tissue secretes chemokines, including Monocyte Chemoattractant Protein-1 (MCP-1) and macrophage Migration Inhibitory Factor (MIF), which contributes to adipose tissue inflammation and insulin resistance. Additionally, growth factors like Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor-Beta (TGF-β) are implicated in adipose tissue angiogenesis and fibrosis. Adipokines exert diverse physiological functions that extend beyond their metabolic roles. Adiponectins, for instance, enhance insulin sensitivity and exert anti-inflammatory effects in various tissues, including the liver, skeletal muscle, and endothelium. Leptin regulates not only energy balance but also neuroendocrine function, reproductive health, and bone metabolism. Adipose tissue-derived cytokines and chemokines modulate immune responses, contributing to the integration of metabolic and immune systems [2].

Literature Review

The dysregulation of adipokines has been implicated in the pathogenesis of metabolic disorders, including obesity; type 2 diabetes mellitus, and cardiovascular diseases. Adipose tissue dysfunction in obesity leads to altered adipokine secretion characterized by decreased adiponectin levels and elevated pro-inflammatory adipokines. These imbalances contribute to systemic insulin resistance, chronic inflammation, and endothelial dysfunction, creating a favorable environment for the development of cardiometabolic complications. Beyond metabolic disorders, adipokines also play significant roles in other chronic diseases. For instance, adiponectins exhibit potential anticancer properties by regulating cell proliferation, apoptosis, and angiogenesis. Leptin has been associated with the progression of certain types of cancer, as it promotes tumor growth and invasiveness. Furthermore, adipokines are implicated in the pathogenesis of chronic kidney disease, neurodegenerative disorders, and autoimmune diseases, providing potential therapeutic targets for intervention [3].

Pro-inflammatory adipokines, such as TNF-α, IL-6, and IL-1β, contribute to the development of chronic low-grade inflammation observed in obesity and metabolic syndrome. These adipokines promote the recruitment and activation of immune cells, such as macrophages and T cells, within adipose tissue. The inflammatory response further enhances the secretion of pro-inflammatory adipokines, forming a positive feedback loop that sustains chronic inflammation. This chronic inflammation is implicated in the pathogenesis of insulin resistance and the development of obesity-related complications, including cardiovascular disease. On the other hand, anti-inflammatory adipokines, such as IL-10 and IL-1Ra, help counteract the pro-inflammatory effects. These adipokines act as immune regulators and play a role in maintaining immune homeostasis. They dampen the inflammatory response and contribute to the resolution of inflammation. Imbalances in the secretion of pro-inflammatory and anti-inflammatory adipokines can disrupt the immune response, leading to chronic inflammation and increased susceptibility to metabolic disorders and other inflammatory conditions.

Insulin resistance is a key feature of metabolic syndrome and type 2 diabetes. Adipokines play a critical role in the development of insulin resistance by affecting insulin signaling pathways in target tissues such as liver, muscle, and adipose tissue. Pro-inflammatory adipokines, including TNF-α and IL-6, can induce insulin resistance by interfering with insulin signaling pathways. These adipokines activate signaling cascades, such as the c-Jun N-terminal Kinase (JNK) pathway, which leads to serine phosphorylation of Insulin Receptor Substrate (IRS) proteins and impairs insulin signaling. This results in reduced glucose uptake and increased hepatic glucose production, contributing to elevated blood glucose levels. In contrast, adiponectin exhibits insulin-sensitizing effects. It enhances insulin sensitivity by activating Adenosine Monophosphate-Activated Protein Kinase (AMPK) and Peroxisome Proliferator-Activated Receptor-alpha (PPAR-α) pathways. Adiponectin promotes glucose uptake in muscle and adipose tissue, reduces hepatic glucose production, and enhances fatty acid oxidation. Reduced levels of adiponectin, commonly observed in obesity, are associated with insulin resistance and an increased risk of developing type 2 diabetes [4].

Discussion

The intricate interplay between pro-inflammatory and anti-inflammatory adipokines, as well as their impact on insulin signaling pathways, highlights the importance of adipokines in metabolic health and disease. Adipokines exert significant influences on cardiovascular health and are implicated in the development of cardiovascular diseases such as atherosclerosis and hypertension. Pro-inflammatory adipokines, including TNF-α and IL-6, promote endothelial dysfunction, a key event in the initiation and progression of atherosclerosis. These adipokines induce the expression of adhesion molecules and chemotactic factors in endothelial cells, leading to the recruitment and adhesion of immune cells, as well as the migration of smooth muscle cells. This sets the stage for the development of atherosclerotic plaques and the narrowing of blood vessels. Moreover, adipokines can influence vascular tone and blood pressure regulation. Adipose tissue-derived factors, such as leptin and resistin, have been shown to increase blood pressure by promoting vasoconstriction and reducing nitric oxide production. Leptin, in particular, has been associated with hypertension, as elevated levels of leptin are often observed in individuals with obesity and hypertension [5].

In contrast, adiponectin exhibits protective effects on the cardiovascular system. Adiponectin improves endothelial function, reduces oxidative stress, and inhibits the adhesion of immune cells to the vascular wall. Low levels of adiponectin are associated with increased cardiovascular risk and adverse cardiovascular events. The intricate relationship between adipokines and cardiovascular health underscores the importance of adipose tissue in maintaining cardiovascular homeostasis and highlights the potential of targeting adipokines for the prevention and treatment of cardiovascular diseases. Adipokines represent a remarkable group of molecules that mediate the communication between adipose tissue and various organs throughout the body. These bioactive substances play critical roles in regulating metabolism, inflammation, and cardiovascular health. Dysregulation of adipokines is implicated in the pathogenesis of metabolic disorders, chronic inflammation, and cardiovascular diseases [6].

Conclusion

Understanding the functions and interactions of adipokines provides valuable insights into the intricate mechanisms underlying metabolic regulation and disease development. The therapeutic potential of adipokines lies in modulating their secretion or signaling pathways to restore metabolic balance and mitigate the associated complications. Future research endeavors should continue to explore the specific roles of adipokines, their underlying mechanisms, and potential therapeutic interventions. By harnessing the power of adipokines, we may uncover novel strategies to combat metabolic disorders and improve overall health outcomes.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Annie, Lalrawngbawli, Guruswami Gurusubramanian and Vikas Kumar Roy. "Estrogen and progesterone dependent expression of visfatin/NAMPT regulates proliferation and apoptosis in mice uterus during estrous cycle."J Steroid Biochem Mol Biol185 (2019): 225-236.

Google Scholar, Crossref, Indexed at

2. Bello, Semiu Folaniyi, Haiping Xu, Lijin Guo and Kan Li, et al. "Hypothalamic and ovarian transcriptome profiling reveals potential candidate genes in low and high egg production of white Muscovy ducks (C. moschata)."Poult Sci 100 (2021): 101310.

Google Scholar, Crossref, Indexed at

3. Carbone, Federico, Luca Liberale, Aldo Bonaventura and Alessandra Vecchiè, et al. "Regulation and function of extracellular nicotinamide phosphoribosyltransferase/visfatin."Compr Physiol 7 (2011): 603-621.

Google Scholar, Crossref, Indexed at

4. Dahl, Tuva B., Sverre Holm, Pål Aukrust and Bente Halvorsen. "Visfatin/NAMPT: A multifaceted molecule with diverse roles in physiology and pathophysiology."Annu Rev Nutr32 (2012): 229-243.

Google Scholar, Crossref, Indexed at

5. Eyal-Giladi, Hefzibah and Shimshon Kochav. "From cleavage to primitive streak formation: A complementary normal table and a new look at the first stages of the development of the chick: I. General morphology."Dev Biol 49 (1976): 321-337.

Google Scholar, Crossref, Indexed at

6. Li, J., F. Meng, C. Song and Y. Wang, et al. "Characterization of chicken visfatin gene: cDNA cloning, tissue distribution, and promoter analysis."Poult Sci 91 (2012): 2885-2894.

Google Scholar, Crossref, Indexed at